Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 24Completed 23Recruiting 17Terminated 11Withdrawn 7Not yet recruiting 3Active not recruiting 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Chemotherapeutic Agent Toxicity 1

Interventions

Specimen Handling 4Educational Status 3Standard of Care 2Practice Guidelines as Topic 2Methods 2Interviews as Topic 2Health Promotion 2Exercise 2Endoscopic Mucosal Resection 2Diet Therapy 2tocilizumab 1lopinavir-ritonavir drug combination 1lavender oil 1jojoba wax 1gallium 68 PSMA-11 1azathiopurine 1apatinib 1Ultrasonography, Doppler 1Ultrasonography 1Transcranial Magnetic Stimulation 1Tomography, Optical Coherence 1Self Expandable Metallic Stents 1Radiosurgery 1Radiofrequency Ablation 1Quality of Life 1Positron-Emission Tomography 1Piperacillin, Tazobactam Drug Combination 1Oxygen Inhalation Therapy 1Nutritional Status 1Nephroureterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Suspended × Cisplatin × Clear all
NCT00695032 2014-11-05

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Institut Claudius Regaud

Phase NA Suspended
80 enrolled
Other solid neoplasm

Chemotherapeutic Agent Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡